EX-PRESS® P-50 and EX-PRESS® P-200 - Trial NCT06119178
Access comprehensive clinical trial information for NCT06119178 through Pure Global AI's free database. This phase not specified trial is sponsored by Alcon Research and is currently Not yet recruiting. The study focuses on Glaucoma. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Alcon Research
Timeline & Enrollment
N/A
Nov 01, 2023
Jul 01, 2024
Primary Outcome
Percentage reduction in intraocular pressure (IOP) from baseline
Summary
The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to assess long term
 clinical performance and safety outcomes for EX-PRESS Glaucoma Filtration Devices Models P-50
 and P-200.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06119178
Device Trial